Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations – mebendazole product and patent listings (2026)

Government Record · U.S. Food and Drug Administration, Office of Generic Drugs · November 19, 2026

U.S. Food et al., 2026-11-19: The current Orange Book data files list three mebendazole chewable-tablet products and, in the patent file, no patent for any of them.

MEBENDAZOLE~TABLET, CHEWABLE;ORAL~EMVERM~IMPAX LABS INC~100MG~A~073580~001~~Jan 4, 1995~No~Yes~RX~IMPAX LABORATORIES INC

U.S. Food et al., 2026-11-19: The current Orange Book data files list three mebendazole chewable-tablet products and, in the patent file, no patent for any of them. Record field transcription from the Orange Book data files (products.txt / patent.txt / exclusivity.txt inside the official ZIP download), access date 2026-11-19; hence MEDIUM. No lines matching MEBENDAZOLE appear in patent.txt or exclusivity.txt, i.e. no listed patent and no listed exclusivity for NDA 017481, NDA 208398 or ANDA 073580. Download URL is a ZIP data file, not a PDF – flagged here so the verifier is not expecting a PDF. Orange Book search pages (accessdata.fda.gov/scripts/cder/ob/) were not reachable from this network; the underlying data file is the same source. access date, page undated.